Actively Recruiting
Effects of Photobiomodulation in Hemophilia Patients.
Led by Riphah International University · Updated on 2026-05-12
24
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hemophilia is a genetic bleeding disorder that commonly leads to knee hemarthrosis, causing pain, swelling, and reduced joint mobility in children. While standard treatments include clotting factor replacement and physiotherapy, additional non-invasive approaches are being explored. This study aims to evaluate the effects of photobiomodulation on knee hemarthrosis in male hemophilia patients aged 9-14 years. It focuses on determining whether this therapy can reduce pain and swelling and improve joint range of motion when used alongside
CONDITIONS
Official Title
Effects of Photobiomodulation in Hemophilia Patients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hemophilia patients with knee hemarthrosis
- Age between 9 and 14 years
- Both male and female patients are eligible
You will not qualify if you...
- Presence of open wounds at or near the treatment site
- Knee joint subluxation
- Presence of congenital or acquired skeletal deformities
- Diagnosis of cardiopulmonary dysfunctions
- Neurological deficits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sundas Foundation
Sialkot, Punjab Province, Pakistan, 5100
Actively Recruiting
Research Team
I
Imran Amjad, PhD
CONTACT
M
Muhammad Asif Javed, PhD*
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here